The American Journal of Managed Care > May 2017
The American Journal of Managed Care - May 2017
May 22, 2017 – Lauren M. Scarpati, PhD; Noam Y. Kirson, PhD; Miriam L. Zichlin, MPH; Zitong B. Jia, BA; Howard G. Birnbaum, PhD; and Jaren C. Howard, PharmD
The healthcare burden of opioid abuse is substantial; abusers often have complex healthcare needs and may require care beyond that which is required to treat abuse.
May 16, 2017 – Reema Harrison, PhD, MSc, BSc, and Albert Wu, MD, MPH
The authors explore the potential value of providing critical incident stress debriefing for health professionals involved in adverse patient safety events and the instances in which this could be routinely implemented.
May 18, 2017 – Ian Randall, PhD; Charles Maynard, PhD; Gary Chan, PhD; Beth Devine, PhD; and Chris Johnson, PhD
This study utilizes a validated instrument to create case and control groups to measure the effect of the Veterans Health Administration (VHA)ís patient-centered medical home (PCMH) model on utilization patterns among veterans with posttraumatic stress disorder (PTSD).
May 26, 2017 – Young Hee Nam, PhD; Dennis G. Shea, PhD; Yunfeng Shi, PhD; and John R. Moran, PhD
This study investigates the impact of state prescription drug monitoring programs on drug overdose mortality rates for all drug categories.
TRENDS FROM THE FIELD
May 18, 2017 – Junqing Liu, PhD; Jonathan Brown, PhD; Suzanne Morton, MPH; D.E.B. Potter, MS; Lisa Patton, PhD; Milesh Patel, MS; Rita Lewis, MPH; and Sarah Hudson Scholle, DrPH
This study highlights disparities in care for diabetes and hypertension for individuals with serious mental illness compared with the general Medicaid and Medicare populations.
May 16, 2017 – G. Thomas Ray, MBA; Amber L. Bahorik, PhD; Paul C. VanVeldhuisen, PhD; Constance M. Weisner, DrPH, MSW; Andrea L. Rubinstein, MD; and Cynthia I. Campbell, PhD, MPH
A flexible population-based prescription opioid registry was established for addressing a broad range of critical public health questions relating to prescription opioid use.
May 16, 2017 – Jason Shafrin, PhD; Felicia Forma, BSc; Ethan Scherer, PhD; Ainslie Hatch, PhD; Edward Vytlacil, PhD; and Darius Lakdawalla, PhD
This study demonstrates that common pharmacy claims-based measures underestimate the effect of actual adherence on inpatient costs among patients with serious mental illness.
May 17, 2017 – Robert J. Romanelli, PhD; Laurence I. Ikeda, MD; Braden Lynch, PharmD; Terri Craig, PharmD; Joseph C. Cappelleri, PhD; Trevor Jukes, MS; and Denis Y. Ishisaka, PharmD
This study identified populations with non-cancer chronic pain to determine which patients may be more likely to receive an opioid prescription in an outpatient setting.
May 19, 2017 – Austin B. Frakt, PhD; Jodie Trafton, PhD; and Steven D. Pizer, PhD
Across many measures of Veterans Health Administration mental health care program characteristics, treatment continuity is most strongly and positively associated with patient satisfaction. ¬†
May 26, 2017 – Gerald Cochran, PhD; Adam J. Gordon, MD, MPH; Walid F. Gellad, MD, MPH; Chung-Chou H. Chang, PhD; Wei-Hsuan Lo-Ciganic, PhD, MS, MSPharm; Carroline Lobo, MS; Evan Cole, PhD; Winfred Frazier, MD; Ping
Enrollees in Medicaid plans employing prior authorization policies for opioid medications may have lower rates of opioid medication abuse and overdose.